Department of Radiology, Nancy University Hospital, Lorraine University, 1 Allée du Morvan, 54511, Vandoeuvre-lès-Nancy, France.
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Dig Dis Sci. 2022 Jun;67(6):2462-2470. doi: 10.1007/s10620-021-07016-z. Epub 2021 Jun 22.
The association between radiological remission and natural history of disease in children with inflammatory bowel diseases (IBD) is poorly known.
(i) To assess the correlation between cross-sectional imaging (CSI) (ultrasound and magnetic resonance imaging) and clinical, biomarker and endoscopic disease activity; (ii) to evaluate the impact of radiological activity on the occurrence of complications in pediatric patients with IBD.
A retrospective study including pediatric patients with IBD and radiological follow-up of at least one year was conducted between 2003 and 2019 at the Nancy University Hospital.
In total, 118 patients (66 Crohn's disease (CD) and 52 ulcerative colitis (UC)) were included. Median follow-up duration was 5.2 years (range: 1.1-15.4). Seventeen (25.8%) patients with CD and 7 (13.5%) patients with UC achieved and maintained radiological remission until last follow-up. No IBD patient achieving radiological remission experienced complications or relapse. In patients not achieving radiologic remission, complications and surgery occurred in 13/49 (26.5%) and 8/49 (16.3%) patients with CD and in 5/45 (11.1%) and 5 (11.1%) subjects with UC. Among patients with CD, the association for remission status between radiological and endoscopic assessment was excellent (Cramer's V test (V) = 0.50), and moderate between radiological and either clinical (V = 0.30) or biochemical (V = 0.33) assessments. In UC, the association for remission status between radiological and either endoscopic or clinical assessments were weak (V = 0.19 and V = 0.20 respectively), and moderate (V = 0.23) between radiological and biochemical assessments.
CSI may replace endoscopic monitoring in pediatric CD. Radiological remission status predicts long-term disease outcomes.
放射学缓解与儿童炎症性肠病(IBD)自然病程之间的关联尚不清楚。
(i)评估横断面成像(CSI)(超声和磁共振成像)与临床、生物标志物和内镜疾病活动之间的相关性;(ii)评估放射学活动对儿科 IBD 患者并发症发生的影响。
这是一项回顾性研究,纳入了 2003 年至 2019 年期间在南锡大学医院接受放射学随访至少一年的儿科 IBD 患者。
共纳入 118 例患者(66 例克罗恩病(CD)和 52 例溃疡性结肠炎(UC))。中位随访时间为 5.2 年(范围:1.1-15.4)。17 例 CD 患者(25.8%)和 7 例 UC 患者(13.5%)达到并维持放射学缓解直至最后一次随访。没有达到放射学缓解的 IBD 患者出现并发症或复发。在未达到放射学缓解的患者中,CD 患者中发生并发症和手术的患者有 13/49(26.5%)和 8/49(16.3%),UC 患者中有 5/45(11.1%)和 5(11.1%)。在 CD 患者中,放射学和内镜评估之间的缓解状态的关联为极好(Cramer's V 检验(V)=0.50),放射学和临床(V=0.30)或生化(V=0.33)评估之间的关联为中度。在 UC 中,放射学和内镜或临床评估之间的缓解状态的关联为弱(V=0.19 和 V=0.20),放射学和生化评估之间的关联为中度(V=0.23)。
CSI 可能取代儿科 CD 的内镜监测。放射学缓解状态预测长期疾病结局。